Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 4
2022 5
2023 8
2024 2
2025 3
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL.
de Boer JW, Keijzer K, van Dorp S, Mutsaers PGNJ, Niezink AGH, van Doesum JA, Serroukh YIM, Muntendam LW, Pulles AE, Kret EJ, Sijs-Szabo A, Oomen J, Demandt AMP, Stevens WBC, Kuipers MT, Pennings ERA, Spanjaart AM, Kersten MJ, Jak M, van Dijk LV, van der Poel MWM, Vermaat JSP, van Meerten T. de Boer JW, et al. Among authors: van doesum ja. Blood Adv. 2025 Nov 11;9(21):5641-5650. doi: 10.1182/bloodadvances.2025016689. Blood Adv. 2025. PMID: 40668622 Free PMC article.
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.
de Boer JW, Keijzer K, van Doesum JA, Smit NAM, Brouwers AH, van Sluis J, Lub-de Hooge MN, Pierik FR, Huls GA, van Dijk LV, Visser L, Diepstra A, Noordzij W, Williams SP, Ungewickell A, Elias SG, de Vries EGE, Niezink AGH, van Meerten T. de Boer JW, et al. Among authors: van doesum ja. Nat Commun. 2025 Nov 25;16(1):11629. doi: 10.1038/s41467-025-66767-9. Nat Commun. 2025. PMID: 41290699 Free PMC article. Clinical Trial.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
Spanjaart AM, Pennings ERA, Kos M, Mutsaers PGNJ, Lugtenburg PJ, van Meerten T, van Doesum JA, Minnema MC, Jak M, van Dorp S, Vermaat JSP, van der Poel MWM, van Oijen MGH, Kuipers MT, Nijhof IS, Kersten MJ. Spanjaart AM, et al. Among authors: van doesum ja. JCO Oncol Pract. 2023 Mar;19(3):e407-e416. doi: 10.1200/OP.22.00501. Epub 2022 Dec 12. JCO Oncol Pract. 2023. PMID: 36508702 Free PMC article.
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Pothast CR, Hofsink Q, Haggenburg S, Dijkland RC, Van de Meent M, Van Dijk K, Bhoekhan MS, Haverkate NJE, Van Meerloo J, Falkenburg JHF, De Groen RAL, Broers AEC, Van Doesum JA, Van Binnendijk RS, Den Hartog G, Lissenberg-Witte BI, Kater AP, Smits GP, Wouters D, Van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Van Baarle D, De Vries RD, Van Meerten T, Mutsaers PGNJ, Goorhuis A, Nijhof IS, Hazenberg MD, Heemskerk MHM, Rutten CE, Study Team CK. Pothast CR, et al. Among authors: van doesum ja. Haematologica. 2025 Nov 1;110(11):2799-2805. doi: 10.3324/haematol.2024.287136. Epub 2025 May 29. Haematologica. 2025. PMID: 40438989 Free PMC article. No abstract available.
High frequency of hyperglycaemia observed during CAR T-cell treatment.
Tienstra M, de Boer JW, van Doesum JA, van Meerten T, van Dijk PR. Tienstra M, et al. Among authors: van doesum ja. Diabet Med. 2023 Feb;40(2):e14969. doi: 10.1111/dme.14969. Epub 2022 Oct 17. Diabet Med. 2023. PMID: 36209376 Free PMC article. No abstract available.
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
de Boer JW, Pennings ERA, Kleinjan A, van Doesum JA, Spanjaart AM, Mutsaers PGNJ, Jak M, van der Poel MWM, Kuipers MT, Adam JA, Diepstra A, Koens L, van Dorp S, Vermaat JSP, Niezink AGH, Kersten MJ, van Meerten T. de Boer JW, et al. Among authors: van doesum ja. Blood Adv. 2023 Nov 14;7(21):6710-6716. doi: 10.1182/bloodadvances.2023010665. Blood Adv. 2023. PMID: 37639324 Free PMC article. No abstract available.
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
Haggenburg S, Hofsink Q, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Zweegman S, Kater AP, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, Beaumont T, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI Study Team. Haggenburg S, et al. Among authors: van doesum ja. JAMA Oncol. 2022 Oct 1;8(10):1477-1483. doi: 10.1001/jamaoncol.2022.3227. JAMA Oncol. 2022. PMID: 35951338 Free PMC article.
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Haggenburg S, Lissenberg-Witte BI, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, de Rooij DM, van Meerloo J, Cloos J, Kootstra NA, Wouters D, Weijers SS, van Leeuwen EMM, Bontkes HJ, Tonouh-Aajoud S, Heemskerk MHM, Sanders RW, Roelandse-Koop E, Hofsink Q, Groen K, Çetinel L, Schellekens L, den Hartog YM, Toussaint B, Kant IMJ, Graas T, de Pater E, Dik WA, Engel MD, Pierie CRN, Janssen SR, van Dijkman E, Poniman M, Burger JA, Bouhuijs JH, Smits G, Rots NY, Zweegman S, Kater AP, van Meerten T, Mutsaers PGNJ, van Doesum JA, Broers AEC, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS. Haggenburg S, et al. Among authors: van doesum ja. Blood Adv. 2022 Mar 8;6(5):1537-1546. doi: 10.1182/bloodadvances.2021006917. Blood Adv. 2022. PMID: 35114690 Free PMC article. Clinical Trial.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
Hofsink Q, Haggenburg S, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, van Meerloo J, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Rots N, van Beek J, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI study team. Hofsink Q, et al. Among authors: van doesum ja. EClinicalMedicine. 2023 Jul;61:102040. doi: 10.1016/j.eclinm.2023.102040. Epub 2023 Jun 15. EClinicalMedicine. 2023. PMID: 37337616 Free PMC article.
23 results